Congenital Disorder of Glycosylation, TYPE IIi
CDG2I

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 7 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Hypotonia nervous 100 % 23228021 2024-05-10
Developmental delay nervous 100 % 23228021 2024-05-10
Mental retardation nervous 86 % 23228021 2024-05-10
Microcephaly nervous 71 % 23228021 2024-05-10
Short stature endocrine 57 % 23228021 2024-05-10
Visual impairment nervous 28 % 23228021 2024-05-10
Cerebellar atrophy nervous 28 % 23228021 2024-05-10
Hearing impairment nervous 28 % 23228021 2024-05-10
Cerebral atrophy nervous 14 % 23228021 2024-05-10
Neurogenic bladder urinary 14 % 23228021 2024-05-10
Contracture nervous 14 % 23228021 2024-05-10
Skin wrinkles integumentary 14 % 23228021 2024-05-10
Seizures nervous 14 % 23228021 2024-05-10



List of references:


COG5-CDG: expanding the clinical spectrum.
Daisy Rymen, Liesbeth Keldermans, Valérie Race, Luc Régal, Nicolas Deconinck, Carlo Dionisi-Vici, Cheuk-Wing Fung, Luisa Sturiale, Claire Rosnoblet, François Foulquier, Gert Matthijs, Jaak Jaeken,



Orphanet journal of rare diseases - Dec 2012